Discontinuation report INVIRASE
Report ID | 132101 |
Drug Identification Number | 02279320 |
Brand name | INVIRASE |
Common or Proper name | PrINVIRASE® (saquinavir mesylate) 500 mg |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SAQUINAVIR |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | Glass or plastic (HDPE) bottles- 270 capsules |
ATC code | J05AE |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-12-31 |
Actual discontinuation date | 2021-01-05 |
Remaining supply date | 2021-06-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | No remaining supply discontinued as of January 2021. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-01-20 | French | Compare |
v3 | 2021-01-20 | French | Compare |
v2 | 2021-01-20 | English | Compare |
v1 | 2021-01-20 | English | Compare |
Showing 1 to 4 of 4